GlassScriptPhysician profile
Robert B Dunne
NPI 1013977503
$20,623.03
in general payments reported to CMS, 2019-2025
10 companies · $6,021 in 2025
The $6,021 reported for 2025 was more than what 99% of Emergency Medical Services providers received nationally (typical 2025 total: $70.35).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,558 · 2020: $200 · 2021: $174 · 2022: $4,015 · 2023: $896 · 2024: $759 · 2025: $6,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,167 · Consulting Fee: $300 · Travel and Lodging: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,167.22 |
| Consulting Fee | $300.00 |
| Travel and Lodging | $209.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $12,020.44 | 2019-2023 | |
| Aero US INC | $5,969.76 | 2024-2025 | Aerogen Solo Nebulizer System, Aerogen Usb Controller System, Aerogen Solo; Aerogen Ultra |
| Stryker Corporation | $1,136.15 | 2019-2025 | Lifepak 35, Physio - Lifenet, Power-Pro |
| Portola Pharmaceuticals, LLC | $322.69 | 2019 | |
| Inari Medical, INC. | $306.83 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Btg International INC. | $244.39 | 2023-2025 | Cyanokit |
| Emergent Biosolutions INC. | $200.00 | 2020 | |
| Zoll Medical Corporation | $177.06 | 2019-2025 | Defibrillator |
| Janssen Pharmaceuticals, INC | $124.38 | 2019 | |
| Neurelis, INC. | $121.33 | 2023 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dunne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.